UNICHEMLAB — Unichem Laboratories Share News
0.000.00%
Last trade - 00:00- IN₹33.30bn
- IN₹35.33bn
- IN₹22.02bn
India's Unichem Laboratories hits record high
India's Unichem Laboratories sees biggest intraday loss in over a month
Brief: Unichem Laboratories Gets ANDA Approval From USFDA For Unichem’S Carbamazepine Tablets USP
Brief: Unichem Laboratories Gets ANDA Approval From USFDA For Quetiapine Extended-Release Tablets
Brief: Unichem Laboratories Received ANDA Approval For Labetalol Hydrochloride Tablets From USFDA
Brief: Unichem Gets ANDA Approval From FDA For Divalproex Sodium Extended-Release Tablets
India's Unichem Labs jumps on U.S. FDA nod for generic version of Schizophrenia treatment
Brief: Unichem Laboratories - Gets ANDA Approval For Metformin Hydrochloride Extended-Release Tablets
India's Unichem Labs jumps on U.S. FDA nod to market AstraZeneca antidepressant
Brief: Unichem Labs Gets ANDA Approval For Guanfacine Tablets From USFDA
Brief: Unichem Laboratories Gets ANDA Approval For Its Apremilast Tablets From FDA
Brief: Unichem Laboratories Gets ANDA Approval From FDA For Zonisamide Capsules
Brief: Unichem Laboratories Gets ANDA Nod From USFDA For Celecoxib Capsules
Brief: Unichem Laboratories Gets ANDA Approval For Tolterodine Tartrate Tablets
Brief: India's Unichem Laboratories Posts June Qtr Consol PAT
Brief: Unichem Laboratories Gets ANDA Approval From USFDA For Amiodarone Tablets
Brief: Unichem Laboratories Ltd Reports March Qtr Loss
Brief: Unichem Laboratories Reports March Qtr Consol Loss 171.9 Mln Rupees
Brief: Unichem Laboratories Gets EIR From FDA For Facility At Roha